{"SPADE_UN_27070": {"basic": {"SPADE ID": "SPADE_UN_27070", "Peptide Name": "LTX-109, Voxvoganan, Lytixar", "Sequence": "RXR", "Source": "", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Target Organism": "Escherichia coli ATCC 25922(MIC=7.5µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=5µg/ml),Staphylococcus aureus ATCC 25923(MIC=2.5µg/ml),Staphylococcus aureus ATCC 33591(MIC=2.5µg/ml),Staphylococcus epidermidis ATCC 27626(MIC=1.0µg/ml),Staphylococcus aureus CCUG 43316(MIC=2.5µg/ml),Staphylococcus aureus(MIC=2-4µg/ml),Staphylococcus aureus(MBC=2-8µg/ml),Escherichia coli ATCC 25922(MIC=2-4µM),Staphylococcus aureus ATCC 29213(MIC=2-4µM),Candida albicans SC5314(MIC=4µM),Candida utilis(MIC=2µM),Aspergillus fumigatus(MIC=8µM),Human cervical carcinoma HeLa(IC50=46.6µM),Escherichia coli ATCC 25922(MIC=3µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=8µg/ml),Staphylococcus aureus ATCC 25923(MIC=2µg/ml)", "Sequence Length": 3}, "extended_data_url": "SPADE_UN_27070_extended.json"}}